HOLLYWOOD, FLA. — The National Comprehensive Cancer Network has updated its thyroid carcinoma guidelines to add consideration of small molecule kinase inhibitors in metastatic disease treatment, refine diagnosis and treatment strategies based on fine needle aspiration, and provide new information on thyroid-stimulating hormone suppression.
PREVIEW